166 related articles for article (PubMed ID: 34281542)
1. A novel prognostic model based on epithelial-mesenchymal transition-related genes predicts patient survival in gastric cancer.
Song W; Bai Y; Zhu J; Zeng F; Yang C; Hu B; Sun M; Li C; Peng S; Chen M; Sun X
World J Surg Oncol; 2021 Jul; 19(1):216. PubMed ID: 34281542
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.
Zhang D; Zhou S; Liu B
Biomed Res Int; 2020; 2020():7082408. PubMed ID: 32309437
[TBL] [Abstract][Full Text] [Related]
4. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
Front Genet; 2021; 12():661306. PubMed ID: 34249086
[TBL] [Abstract][Full Text] [Related]
5. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer.
Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X
Front Oncol; 2021; 11():799223. PubMed ID: 35096599
[TBL] [Abstract][Full Text] [Related]
7. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
Lin Y; Zhang L; Zhang X; Wei X; Liu X; Xie Y; Han G
J Environ Pathol Toxicol Oncol; 2023; 42(4):61-68. PubMed ID: 37522568
[TBL] [Abstract][Full Text] [Related]
8. A Novel Six-Gene-Based Prognostic Model Predicts Survival and Clinical Risk Score for Gastric Cancer.
Li J; Pu K; Li C; Wang Y; Zhou Y
Front Genet; 2021; 12():615834. PubMed ID: 33692828
[No Abstract] [Full Text] [Related]
9. Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis.
Xu H; Wan H; Zhu M; Feng L; Zhang H; Su F
Biomed Res Int; 2021; 2021():9026918. PubMed ID: 34746312
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of an epithelial-mesenchymal transition-related lncRNA pairs prognostic model for gastric cancer.
Song W; Zhu J; Li C; Peng S; Sun M; Li Y; Sun X
Transl Cancer Res; 2023 May; 12(5):1196-1209. PubMed ID: 37304549
[TBL] [Abstract][Full Text] [Related]
11. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer.
Song J; Wei R; Huo S; Gao J; Liu X
Front Immunol; 2022; 13():920512. PubMed ID: 35769483
[TBL] [Abstract][Full Text] [Related]
12. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
13. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
[TBL] [Abstract][Full Text] [Related]
14. Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.
Tang Y; Jiang Y; Qing C; Wang J; Zeng Z
Aging (Albany NY); 2020 Dec; 13(1):794-812. PubMed ID: 33340396
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of microRNA-376a in Gastric Cancer and Association with Poor Prognosis.
Zhang C; Liang Y; Ma MH; Wu KZ; Zhang CD; Dai DQ
Cell Physiol Biochem; 2018; 51(5):2010-2018. PubMed ID: 30522118
[TBL] [Abstract][Full Text] [Related]
16. COL8A1 Predicts the Clinical Prognosis of Gastric Cancer and Is Related to Epithelial-Mesenchymal Transition.
She Y; Zhao X; Wu P; Xue L; Wan S; Zhang L; Li C; Cai H; Li Y
Biomed Res Int; 2022; 2022():7567447. PubMed ID: 35774273
[TBL] [Abstract][Full Text] [Related]
17. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of critical genes with prognostic value in gastric cancer.
Dong N; Ma X; Shen J; Zheng Y; Li G; Zheng S; Huang X
Front Cell Dev Biol; 2022; 10():1072062. PubMed ID: 36589754
[No Abstract] [Full Text] [Related]
19. Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival.
Dai J; Li ZX; Zhang Y; Ma JL; Zhou T; You WC; Li WQ; Pan KF
Clin Transl Gastroenterol; 2019 Jan; 10(1):e00004. PubMed ID: 30702489
[TBL] [Abstract][Full Text] [Related]
20. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
